COPD COPD Genome-Wide Association Study Reveals Numerous Risk Variants The two genome-wide association studies of chronic obstructive pulmonary disease uncovered numerous novel risk variants, including ones in genes involved in ciliogenesis and lung development. Genomics Medicine Ireland, Academic Collaborators to Study Asthma Genetics The partners aim to identify genetic factors common to individuals with asthma and asthma-chronic obstructive pulmonary disease overlap syndrome. Owlstone Medical, AstraZeneca Ink Deal for Breath Biomarker Platform Owlstone will give AstraZeneca access to its Breath Biopsy Services to identify breath-based biomarkers for stratifying and treating asthma and COPD patients. Hummingbird Diagnostics, Saarland University Form Biomarker Validation Partnership The partners plan to validate blood-based microRNAs as biomarkers for the early detection of pulmonary and neurodegenerative diseases. Q&A: Dana-Farber's Quackenbush Ties SNP Analysis to Networks Premium At Bio-IT World, Harvard bioinformatics researcher John Quackenbush called typical methods for determining genetic relevance relics of "Mendel and his peas." Jan 24, 2017 Rare Variants Influence COPD Risk, Targeted Sequencing Study Finds Jan 11, 2017 COPD Foundation, Bio-Techne Test Predictive Emphysema Biomarker May 6, 2016 BioScale Changes Name to ProterixBio, Shifts Focus From Instruments to Diagnostics Premium Sep 28, 2015 GWAS Yields New Loci Linked to Lung Function, Smoking Behavior Dec 15, 2014 Glyconics Inks Exclusive Licensing Deal with Swansea U for COPD Biomarker Detection Jun 4, 2014 Glyconics Launches with FTIR Technology to Detect COPD, Other Respiratory Diseases Dec 5, 2013 University of British Columbia Team Lands C$7.2M to Develop COPD Dx Dec 5, 2012 HTG to Commercialize PROOF's COPD Risk Stratification Test; Aims for Launch Next Year Premium Nov 27, 2012 HTG Molecular Dx Licenses PROOF Centre COPD Testing Tech Apr 25, 2012 Canada's PROOF Center to Develop Risk Stratification Test to Personalize COPD Treatment Premium Apr 17, 2012 PROOF Centre Uses Genome BC Funds for COPD Dx Jan 19, 2012 UPenn Gets $2.5M for Lung Repair, Regeneration Studies Jul 30, 2010 Thermo Fisher to Collaborate with Japanese Researchers on Tokyo-Based Biomarker Research Center Premium Mar 8, 2010 NIH Plans $24M for Lung Cancer-COPD Genotype, Phenotype Studies Feb 4, 2010 University of Pittsburgh Earmarks $350K from NIH Grant for WaferGen Real-Time PCR Studies Premium Apr 22, 2009 Celera 'Expediting' Lung Cancer Dx Development Based on Promising Study Results Premium Apr 2, 2009 Proteros Fragments Inks First Deal to Uncover Protein Structure of Novel Protein Found by Axikin Pharma Premium Breaking News Lander, Collins Offer Vision for Advanced Research Projects Agency for Health LetsGetChecked Partners With California Department of Public Health for COVID-19 Sequencing BTIG Initiates Coverage of Berkeley Lights With Buy Rating Quest Diagnostics to Offer Biocept's Target Selector NGS Lung Cancer Test Novacyt 2020 Revenues Surge on Strong Demand for SARS-CoV-2 Testing Products Leidos Wins CDC Bioinformatics Contract Worth up to $13M The Scan Could Cost Billions NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars. Not Quite Sent The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post. DTC Regulation Proposals A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports. PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.